These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26458057)

  • 1. CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates.
    Hartmann EM; Rudelius M; Burger JA; Rosenwald A
    Leuk Lymphoma; 2016; 57(3):563-71. PubMed ID: 26458057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
    Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
    Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL3 as Possible Negative Prognostic Factor in Chronic Lymphocytic Leukemia.
    Popek-Marciniec S; Zmorzyński S; Koczkodaj D; Marciniec M; Wąsik-Szczepanek E; Karczmarczyk A; Michalak-Wojnowska M; Filip A
    Acta Haematol; 2023; 146(4):277-286. PubMed ID: 37015191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.
    Burger JA; Quiroga MP; Hartmann E; Bürkle A; Wierda WG; Keating MJ; Rosenwald A
    Blood; 2009 Mar; 113(13):3050-8. PubMed ID: 19074730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen.
    Lampert IA; Wotherspoon A; Van Noorden S; Hasserjian RP
    Hum Pathol; 1999 Jun; 30(6):648-54. PubMed ID: 10374772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
    Herishanu Y; Pérez-Galán P; Liu D; Biancotto A; Pittaluga S; Vire B; Gibellini F; Njuguna N; Lee E; Stennett L; Raghavachari N; Liu P; McCoy JP; Raffeld M; Stetler-Stevenson M; Yuan C; Sherry R; Arthur DC; Maric I; White T; Marti GE; Munson P; Wilson WH; Wiestner A
    Blood; 2011 Jan; 117(2):563-74. PubMed ID: 20940416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.
    Niemann CU; Herman SE; Maric I; Gomez-Rodriguez J; Biancotto A; Chang BY; Martyr S; Stetler-Stevenson M; Yuan CM; Calvo KR; Braylan RC; Valdez J; Lee YS; Wong DH; Jones J; Sun C; Marti GE; Farooqui MZ; Wiestner A
    Clin Cancer Res; 2016 Apr; 22(7):1572-82. PubMed ID: 26660519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia.
    Sivina M; Hartmann E; Kipps TJ; Rassenti L; Krupnik D; Lerner S; LaPushin R; Xiao L; Huang X; Werner L; Neuberg D; Kantarjian H; O'Brien S; Wierda WG; Keating MJ; Rosenwald A; Burger JA
    Blood; 2011 Feb; 117(5):1662-9. PubMed ID: 21115978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node histology in typical and atypical chronic lymphocytic leukemia.
    Bonato M; Pittaluga S; Tierens A; Criel A; Verhoef G; Wlodarska I; Vanutysel L; Michaux L; Vandekerckhove P; Van den Berghe H; De Wolf-Peeters C
    Am J Surg Pathol; 1998 Jan; 22(1):49-56. PubMed ID: 9422315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes.
    Szurián K; Csala I; Marosvári D; Rajnai H; Dezső K; Bödör C; Piurkó V; Matolcsy A; Reiniger L
    Exp Mol Pathol; 2018 Oct; 105(2):161-165. PubMed ID: 30031020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias.
    Lad DP; Varma S; Varma N; Sachdeva MU; Bose P; Malhotra P
    Leuk Lymphoma; 2015; 56(8):2424-8. PubMed ID: 25393804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
    Zucchetto A; Benedetti D; Tripodo C; Bomben R; Dal Bo M; Marconi D; Bossi F; Lorenzon D; Degan M; Rossi FM; Rossi D; Bulian P; Franco V; Del Poeta G; Deaglio S; Gaidano G; Tedesco F; Malavasi F; Gattei V
    Cancer Res; 2009 May; 69(9):4001-9. PubMed ID: 19383907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.
    Cuesta-Mateos C; Brown JR; Terrón F; Muñoz-Calleja C
    Front Immunol; 2021; 12():662866. PubMed ID: 33841445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioredoxin, produced by stromal cells retrieved from the lymph node microenvironment, rescues chronic lymphocytic leukemia cells from apoptosis in vitro.
    Bäckman E; Bergh AC; Lagerdahl I; Rydberg B; Sundström C; Tobin G; Rosenquist R; Linderholm M; Rosén A
    Haematologica; 2007 Nov; 92(11):1495-504. PubMed ID: 18024398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment.
    Ferretti E; Bertolotto M; Deaglio S; Tripodo C; Ribatti D; Audrito V; Blengio F; Matis S; Zupo S; Rossi D; Ottonello L; Gaidano G; Malavasi F; Pistoia V; Corcione A
    Leukemia; 2011 Aug; 25(8):1268-77. PubMed ID: 21546901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes.
    Till KJ; Lin K; Zuzel M; Cawley JC
    Blood; 2002 Apr; 99(8):2977-84. PubMed ID: 11929789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relevance of cytological studies and Ki-67 reactivity to the clinical course of chronic lymphocytic leukemia.
    Astsaturov IA; Samoilova RS; Iakhnina EI; Pivnik AV; Vorobiov AI
    Leuk Lymphoma; 1997 Jul; 26(3-4):337-42. PubMed ID: 9322896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of patients with chronic lymphocytic leukemia.
    Sachanas S; Levidou G; Angelopoulou MK; Moschogiannis M; Yiakoumis X; Kalpadakis C; Vassilakopoulos TP; Kontopidou F; Tsirkinidis P; Dimitrakopoulou A; Kokoris S; Dimitriadou E; Kyrtsonis MC; Panayiotidis P; Papadaki H; Patsouris E; Korkolopoulou P; Pangalis GA
    Leuk Lymphoma; 2014 Mar; 55(3):571-82. PubMed ID: 23697878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.